User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Safety of drug treatments for head and neck cancer

Primary tabs

Galot, Rachel [UCL] Machiels, Jean-Pascal [UCL]

The treatment of squamous cell carcinoma of the head and the neck depends on the disease's stage. In locally-advanced stage disease, multimodal treatment strategies, including surgery, radiotherapy and chemotherapy, give the best outcome in terms of overall survival. Those treatments are not without negligeable adverse events, which can lead to late debilitating toxicities. In recurrent/metastatic disease, not amenable to surgery or radiation therapy, palliative chemotherapy is the most appropriate treatment. Areas covered: This review aims to provide an overview of the safety of standard drug regimens used to treat SCCHN in daily practice, including platinum-based chemoradiation, induction chemotherapy, cetuximab and immunotherapy. The toxicities induced by single modality radiotherapy, or those resulting from surgery, are not part of the discussion. Expert opinion: Toxicities observed with multimodal treatment of SCCHN are the highest we can tolerate in terms of treatment-related mortality, morbidity and late consequences. Patients at high risk of developing such complications should be identified upfront for optimal prevention and management. There is a medical need to identify less toxic regimens without compromising the treatment efficacy, especially for patients with Human Papilloma Virus-induced oropharyngeal cancers. Finally, it is crucial in future trials to better standardize the scales used to report treatment related adverse events.

Document type Article de périodique (Journal article) – Article de recherche
Publication date 2016
Language Anglais
Journal information "Expert Opinion on Drug Safety" - Vol. 15, no.11, p. 1527-1539 (2016)
Peer reviewed yes
Publisher Informa Healthcare ((United Kingdom) London)
issn 1474-0338
e-issn 1744-764X
Publication status Publié
Affiliations UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie
UCL - (SLuc) Unité d'oncologie médicale
Keywords Cetuximab ; Chemoradiation ; Immunotherapy ; Induction chemotherapy ; Safety of treatment ; Squamous cell carcinoma of the head and the neck ; Toxicity
Links
  1. Ferlay Jacques, Soerjomataram Isabelle, Dikshit Rajesh, Eser Sultan, Mathers Colin, Rebelo Marise, Parkin Donald Maxwell, Forman David, Bray Freddie, Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 : Globocan 2012, 10.1002/ijc.29210
  2. Ferretti S, Epidemiol Prev, 34, 125 (2010)
  3. Pfister David G., Ang Kie-Kian, Brizel David M., Burtness Barbara A., Busse Paul M., Caudell Jimmy J., Cmelak Anthony J., Colevas A. Dimitrios, Dunphy Frank, Eisele David W., Gilbert Jill, Gillison Maura L., Haddad Robert I., Haughey Bruce H., Hicks Wesley L., Hitchcock Ying J., Kies Merrill S., Lydiatt William M., Maghami Ellie, Martins Renato, McCaffrey Thomas, Mittal Bharat B., Pinto Harlan A., Ridge John A., Samant Sandeep, Schuller David E., Shah Jatin P., Spencer Sharon, Weber Randal S., Wolf Gregory T., Worden Frank, Yom Sue S., McMillian Nicole R., Hughes Miranda, Head and Neck Cancers, Version 2.2013, 10.6004/jnccn.2013.0113
  4. Pignon Jean-Pierre, Maître Aurélie le, Maillard Emilie, Bourhis Jean, Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients, 10.1016/j.radonc.2009.04.014
  5. Browman G P, Cripps C, Hodson D I, Eapen L, Sathya J, Levine M N, Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer., 10.1200/jco.1994.12.12.2648
  6. Gupta N.K., Pointon R.C.S., Wilkinson P.M., A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer, 10.1016/s0009-9260(87)80327-6
  7. Eschwege F, NCI Monogr, 6, 275 (1988)
  8. Haffty B G, Son Y H, Papac R, Sasaki C T, Weissberg J B, Fischer D, Rockwell S, Sartorelli A C, Fischer J J, Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials., 10.1200/jco.1997.15.1.268
  9. Adelstein David J., Saxton Jerrold P., Lavertu Pierre, Tuason Laurie, Wood Benjamin G., Wanamaker John R., Eliachar Isaac, Strome Marshall, Van Kirk Marjorie A., A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results, 10.1002/(sici)1097-0347(199710)19:7<567::aid-hed2>3.0.co;2-5
  10. Wendt T G, Grabenbauer G G, Rödel C M, Thiel H J, Aydin H, Rohloff R, Wustrow T P, Iro H, Popella C, Schalhorn A, Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study., 10.1200/jco.1998.16.4.1318
  11. Brizel David M., Albers Mary E., Fisher Samuel R., Scher Richard L., Richtsmeier William J., Hars Vera, George Stephen L., Huang Andrew T., Prosnitz Leonard R., Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer, 10.1056/nejm199806183382503
  12. Calais Gilles, Alfonsi Marc, Bardet Etienne, Sire Christian, Germain Thierry, Bergerot Philippe, Rhein Béatrix, Tortochaux Jacques, Oudinot Patrick, Bertrand Philippe, Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma, 10.1093/jnci/91.24.2081
  13. Adelstein David J., Li Yi, Adams George L., Wagner Henry, Kish Julie A., Ensley John F., Schuller David E., Forastiere Arlene A., An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer, 10.1200/jco.2003.01.008
  14. Denis Fabrice, Garaud Pascal, Bardet Etienne, Alfonsi Marc, Sire Christian, Germain Thierry, Bergerot Philippe, Rhein Béatrix, Tortochaux Jacques, Oudinot Patrick, Calais Gilles, Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems, 10.1016/s0360-3016(02)03819-1
  15. Hitt R., Grau J. J., López-Pousa A., Berrocal A., García-Girón C., Irigoyen A., Sastre J., Martínez-Trufero J., Brandariz Castelo J. A., Verger E., Cruz-Hernández J. J., Almodóvar C., Cortés-Funes H., Escobar Y., Fonseca-Sánchez E., Galcerán J.C., Guix M., Isla-Casado D., Jara-Sánchez C., Leitão-Silva M.R., Mel-Lorenzo J.R., Pastor-Borgoñón M., Pastor-Gaitán P., Rodríguez-Jaráiz A., Millán J.M., Satrustegui-Galdona J., Moreno M., Estefanía E., Santiago E., García J.J., A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer, 10.1093/annonc/mdt461
  16. Cohen Ezra E.W., Karrison Theodore G., Kocherginsky Masha, Mueller Jeffrey, Egan Robyn, Huang Chao H., Brockstein Bruce E., Agulnik Mark B., Mittal Bharat B., Yunus Furhan, Samant Sandeep, Raez Luis E., Mehra Ranee, Kumar Priya, Ondrey Frank, Marchand Patrice, Braegas Bettina, Seiwert Tanguy Y., Villaflor Victoria M., Haraf Daniel J., Vokes Everett E., Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer, 10.1200/jco.2013.54.6309
  17. Haddad Robert, O'Neill Anne, Rabinowits Guilherme, Tishler Roy, Khuri Fadlo, Adkins Douglas, Clark Joseph, Sarlis Nicholas, Lorch Jochen, Beitler Jonathan J, Limaye Sewanti, Riley Sarah, Posner Marshall, Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial, 10.1016/s1470-2045(13)70011-1
  18. Ghi MGPA FD, J Clinical Oncol, 32, 6004 (2014)
  19. Bernier Jacques, Domenge Christian, Ozsahin Mahmut, Matuszewska Katarzyna, Lefèbvre Jean-Louis, Greiner Richard H., Giralt Jordi, Maingon Philippe, Rolland Frédéric, Bolla Michel, Cognetti Francesco, Bourhis Jean, Kirkpatrick Anne, van Glabbeke Martine, Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer, 10.1056/nejmoa032641
  20. Cooper Jay S., Pajak Thomas F., Forastiere Arlene A., Jacobs John, Campbell Bruce H., Saxman Scott B., Kish Julie A., Kim Harold E., Cmelak Anthony J., Rotman Marvin, Machtay Mitchell, Ensley John F., Chao K.S. Clifford, Schultz Christopher J., Lee Nancy, Fu Karen K., Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck, 10.1056/nejmoa032646
  21. Cooper Jay S., Zhang Qiang, Pajak Thomas F., Forastiere Arlene A., Jacobs John, Saxman Scott B., Kish Julie A., Kim Harold E., Cmelak Anthony J., Rotman Marvin, Lustig Robert, Ensley John F., Thorstad Wade, Schultz Christopher J., Yom Sue S., Ang K. Kian, Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck, 10.1016/j.ijrobp.2012.05.008
  22. Lefebvre J.-L., Chevalier D., Luboinski B., Kirkpatrick A., Collette L., Sahmoud T., Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III Trial, 10.1093/jnci/88.13.890
  23. Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal Cancer, 10.1056/nejm199106133242402
  24. Forastiere Arlene A., Goepfert Helmuth, Maor Moshe, Pajak Thomas F., Weber Randal, Morrison William, Glisson Bonnie, Trotti Andy, Ridge John A., Chao Clifford, Peters Glen, Lee Ding-Jen, Leaf Andrea, Ensley John, Cooper Jay, Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer, 10.1056/nejmoa031317
  25. Prades Jean-Michel, Lallemant Benjamin, Garrel Renaud, Reyt Emile, Righini Christian, Schmitt Thierry, Remini Nagib, Saban-Roche Lea, Timoshenko Andrei P., Trombert Beatrice, Guerrier Bernard, Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma, 10.3109/00016480902914080
  26. Lefebvre J. L., Rolland F., Tesselaar M., Bardet E., Leemans C. R., Geoffrois L., Hupperets P., Barzan L., de Raucourt D., Chevalier D., Licitra L., Lunghi F., Stupp R., Lacombe D., Bogaerts J., Horiot J. C., Bernier J., Vermorken J. B., , Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy, 10.1093/jnci/djn460
  27. Forastiere Arlene A., Zhang Qiang, Weber Randal S., Maor Moshe H., Goepfert Helmuth, Pajak Thomas F., Morrison William, Glisson Bonnie, Trotti Andy, Ridge John A., Thorstad Wade, Wagner Henry, Ensley John F., Cooper Jay S., Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer, 10.1200/jco.2012.43.6097
  28. Vermorken Jan B., Remenar Eva, van Herpen Carla, Gorlia Thierry, Mesia Ricard, Degardin Marian, Stewart John S., Jelic Svetislav, Betka Jan, Preiss Joachim H., van den Weyngaert Danielle, Awada Ahmad, Cupissol Didier, Kienzer Heinz R., Rey Augustin, Desaunois Isabelle, Bernier Jacques, Lefebvre Jean-Louis, Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer, 10.1056/nejmoa071028
  29. Posner Marshall R., Hershock Diane M., Blajman Cesar R., Mickiewicz Elizabeth, Winquist Eric, Gorbounova Vera, Tjulandin Sergei, Shin Dong M., Cullen Kevin, Ervin Thomas J., Murphy Barbara A., Raez Luis E., Cohen Roger B., Spaulding Monica, Tishler Roy B., Roth Berta, Viroglio Rosana del Carmen, Venkatesan Varagur, Romanov Ilya, Agarwala Sanjiv, Harter K. William, Dugan Matthew, Cmelak Anthony, Markoe Arnold M., Read Paul W., Steinbrenner Lynn, Colevas A. Dimitrios, Norris Charles M., Haddad Robert I., Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer, 10.1056/nejmoa070956
  30. Pignon JP, Bourhis J, Domenge C, Designé L, Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data, 10.1016/s0140-6736(00)90011-4
  31. Pointreau Y., Garaud P., Chapet S., Sire C., Tuchais C., Tortochaux J., Faivre S., Guerrif S., Alfonsi M., Calais G., Randomized Trial of Induction Chemotherapy With Cisplatin and 5-Fluorouracil With or Without Docetaxel for Larynx Preservation, 10.1093/jnci/djp007
  32. Bonner James A., Harari Paul M., Giralt Jordi, Azarnia Nozar, Shin Dong M., Cohen Roger B., Jones Christopher U., Sur Ranjan, Raben David, Jassem Jacek, Ove Roger, Kies Merrill S., Baselga Jose, Youssoufian Hagop, Amellal Nadia, Rowinsky Eric K., Ang K. Kian, Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck, 10.1056/nejmoa053422
  33. Magrini Stefano Maria, Buglione Michela, Corvò Renzo, Pirtoli Luigi, Paiar Fabiola, Ponticelli Pietro, Petrucci Alessia, Bacigalupo Almalina, Crociani Monica, Lastrucci Luciana, Vecchio Stefania, Bonomo Pierluigi, Pasinetti Nadia, Triggiani Luca, Cavagnini Roberta, Costa Loredana, Tonoli Sandro, Maddalo Marta, Grisanti Salvatore, Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial, 10.1200/jco.2015.63.1671
  34. Ang K. Kian, Zhang Qiang, Rosenthal David I., Nguyen-Tan Phuc Felix, Sherman Eric J., Weber Randal S., Galvin James M., Bonner James A., Harris Jonathan, El-Naggar Adel K., Gillison Maura L., Jordan Richard C., Konski Andre A., Thorstad Wade L., Trotti Andy, Beitler Jonathan J., Garden Adam S., Spanos William J., Yom Sue S., Axelrod Rita S., Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522, 10.1200/jco.2013.53.5633
  35. Vermorken Jan B., Mesia Ricard, Rivera Fernando, Remenar Eva, Kawecki Andrzej, Rottey Sylvie, Erfan Jozsef, Zabolotnyy Dmytro, Kienzer Heinz-Roland, Cupissol Didier, Peyrade Frederic, Benasso Marco, Vynnychenko Ihor, De Raucourt Dominique, Bokemeyer Carsten, Schueler Armin, Amellal Nadia, Hitt Ricardo, Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer, 10.1056/nejmoa0802656
  36. Seiwert Tanguy Y, Burtness Barbara, Mehra Ranee, Weiss Jared, Berger Raanan, Eder Joseph Paul, Heath Karl, McClanahan Terrill, Lunceford Jared, Gause Christine, Cheng Jonathan D, Chow Laura Q, Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial, 10.1016/s1470-2045(16)30066-3
  37. Segal NH, J Clinical Oncol, 33, 301 (2015)
  38. Ferris RL, J Clin Oncol, 2016, 34 (2016)
  39. Lefebvre Jean Louis, Pointreau Yoann, Rolland Frederic, Alfonsi Marc, Baudoux Alain, Sire Christian, de Raucourt Dominique, Malard Olivier, Degardin Marian, Tuchais Claude, Blot Emmanuel, Rives Michel, Reyt Emile, Tourani Jean Marc, Geoffrois Lionel, Peyrade Frederic, Guichard Francois, Chevalier Dominique, Babin Emmanuel, Lang Philippe, Janot Francois, Calais Gilles, Garaud Pascal, Bardet Etienne, Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study, 10.1200/jco.2012.42.3988
  40. Overgaard J., Sand Hansen H., Andersen A.P., Hjelm-Hansen M., Jørgensen K., Sandberg E., Berthelsen A., Hammer R., Pedersen M., Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: Report from the DAHANCA 2 study, 10.1016/0360-3016(89)90917-6
  41. Saunders ME, Br J Cancer Suppl, 3, 268 (1978)
  42. Overgaard Jens, Sand Hansen Hanne, Overgaard Marie, Bastholt Lars, Berthelsen Anne, Specht Lena, Lindeløv Birgit, Jørgensen Karsten, A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85, 10.1016/s0167-8140(97)00220-x
  43. Moore Eric J., Olsen Steven M., Laborde Rebecca R., García Joaquín J., Walsh Francis J., Price Daniel L., Janus Jeffrey R., Kasperbauer Jan L., Olsen Kerry D., Long-term Functional and Oncologic Results of Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma, 10.1016/j.mayocp.2011.10.007
  44. Haughey Bruce H., Hinni Michael L., Salassa John R., Hayden Richard E., Grant David G., Rich Jason T., Milov Simon, Lewis James S., Krishna Murli, Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: A united states multicenter study, 10.1002/hed.21669
  45. Nutting Christopher M, Morden James P, Harrington Kevin J, Urbano Teresa Guerrero, Bhide Shreerang A, Clark Catharine, Miles Elizabeth A, Miah Aisha B, Newbold Kate, Tanay MaryAnne, Adab Fawzi, Jefferies Sarah J, Scrase Christopher, Yap Beng K, A'Hern Roger P, Sydenham Mark A, Emson Marie, Hall Emma, Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial, 10.1016/s1470-2045(10)70290-4
  46. Ben-David Merav A., Diamante Maximiliano, Radawski Jeffrey D., Vineberg Karen A., Stroup Cynthia, Murdoch-Kinch Carol-Anne, Zwetchkenbaum Samuel R., Eisbruch Avraham, Lack of Osteoradionecrosis of the Mandible After Intensity-Modulated Radiotherapy for Head and Neck Cancer: Likely Contributions of Both Dental Care and Improved Dose Distributions, 10.1016/j.ijrobp.2006.11.059
  47. Trotti Andy, Pajak Thomas F, Gwede Clement K, Paulus Rebecca, Cooper Jay, Forastiere Arlene, Ridge John A, Watkins-Bruner Deborah, Garden Adam S, Ang K Kian, Curran Wally, TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group, 10.1016/s1470-2045(07)70144-4
  48. Machtay Mitchell, Moughan Jennifer, Trotti Andrew, Garden Adam S., Weber Randal S., Cooper Jay S., Forastiere Arlene, Ang K. Kian, Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis, 10.1200/jco.2007.14.8841
  49. Russi Elvio G., Moretto Francesco, Rampino Monica, Benasso Marco, Bacigalupo Almalina, De Sanctis Vitaliana, Numico Gianmauro, Bossi Paolo, Buglione Michela, Lombardo Antonino, Airoldi Mario, Merlano Marco C., Licitra Lisa, Denaro Nerina, Pergolizzi Stefano, Pinto Carmine, Bensadoun Renè- Jean, Girolomoni Giampiero, Langendijk Johannes A., Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus, 10.1016/j.critrevonc.2015.06.001
  50. Buglione Michela, Cavagnini Roberta, Di Rosario Federico, Sottocornola Lara, Maddalo Marta, Vassalli Lucia, Grisanti Salvatore, Salgarello Stefano, Orlandi Ester, Paganelli Corrado, Majorana Alessandra, Gastaldi Giorgio, Bossi Paolo, Berruti Alfredo, Pavanato Giovanni, Nicolai Piero, Maroldi Roberto, Barasch Andrei, Russi Elvio G., Raber-Durlacher Judith, Murphy Barbara, Magrini Stefano M., Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement, 10.1016/j.critrevonc.2015.08.010
  51. Schindler Antonio, Denaro Nerina, Russi Elvio G., Pizzorni Nicole, Bossi Paolo, Merlotti Anna, Spadola Bissetti Massimo, Numico Gianmauro, Gava Alessandro, Orlandi Ester, Caspiani Orietta, Buglione Michela, Alterio Daniela, Bacigalupo Almalina, De Sanctis Vitaliana, Pavanato Giovanni, Ripamonti Carla, Merlano Marco C., Licitra Lisa, Sanguineti Giuseppe, Langendijk Johannes A., Murphy Barbara, Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus, 10.1016/j.critrevonc.2015.06.005
  52. Mirabile A., Airoldi M., Ripamonti C., Bolner A., Murphy B., Russi E., Numico G., Licitra L., Bossi P., Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations, 10.1016/j.critrevonc.2015.11.010
  53. Mirabile Aurora, Numico Gianmauro, Russi Elvio G., Bossi Paolo, Crippa Fulvio, Bacigalupo Almalina, De Sanctis Vitaliana, Musso Stefania, Merlotti Anna, Ghi Maria Grazia, Merlano Marco C., Licitra Lisa, Moretto Francesco, Denaro Nerina, Caspiani Orietta, Buglione Michela, Pergolizzi Stefano, Cascio Antonio, Bernier Jacques, Raber-Durlacher Judith, Vermorken Jan B., Murphy Barbara, Ranieri Marco V., Dellinger R. Phillip, Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus, 10.1016/j.critrevonc.2015.03.003
  54. Ang K. Kian, Harris Jonathan, Wheeler Richard, Weber Randal, Rosenthal David I., Nguyen-Tân Phuc Felix, Westra William H., Chung Christine H., Jordan Richard C., Lu Charles, Kim Harold, Axelrod Rita, Silverman C. Craig, Redmond Kevin P., Gillison Maura L., Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer, 10.1056/nejmoa0912217
  55. Fakhry Carole, Zhang Qiang, Nguyen-Tan Phuc Felix, Rosenthal David, El-Naggar Adel, Garden Adam S., Soulieres Denis, Trotti Andy, Avizonis Vilija, Ridge John Andrew, Harris Jonathan, Le Quynh-Thu, Gillison Maura, Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma, 10.1200/jco.2014.55.1937
  56. O'Sullivan Brian, Huang Shao Hui, Su Jie, Garden Adam S, Sturgis Erich M, Dahlstrom Kristina, Lee Nancy, Riaz Nadeem, Pei Xin, Koyfman Shlomo A, Adelstein David, Burkey Brian B, Friborg Jeppe, Kristensen Claus A, Gothelf Anita B, Hoebers Frank, Kremer Bernd, Speel Ernst-Jan, Bowles Daniel W, Raben David, Karam Sana D, Yu Eugene, Xu Wei, Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study, 10.1016/s1470-2045(15)00560-4
  57. Cmelak A, J Clinical Oncol, 32, LBA6006 (2014)
  58. Rosenthal David I., Harari Paul M., Giralt Jordi, Bell Diana, Raben David, Liu Joyce, Schulten Jeltje, Ang Kian K., Bonner James A., Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab, 10.1200/jco.2015.62.5970
Bibliographic reference Galot, Rachel ; Machiels, Jean-Pascal. Safety of drug treatments for head and neck cancer. In: Expert Opinion on Drug Safety, Vol. 15, no.11, p. 1527-1539 (2016)
Permanent URL http://hdl.handle.net/2078.1/182654